Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Most Read

  1. Novartis’ Cosentyx outperforms Humira in PsA-specific endpoints
  2. FDA approves Janssen’s Stelara for adults with UC
  3. EC expands label of Janssen’s Stelara to include ulcerative colitis
  4. Psoriasis Action Month: using genetics to improve drug development
  5. Janssen’s Tremfya shows promise in two Phase III psoriatic arthritis trials

Company A-Z

Latest Content

Psoriasis Action Month: using genetics to improve drug development

The role of a patient’s genes in causing inflammatory skin condition psoriasis has been largely accepted in the medical community over the past few decades. This has led to significant research into precisely which genes are associated with the condition and how this understanding can better inform drug development, as well as ensure there are effective treatments for more patients.

Diabetes Week: investigating the immune basis of type 1 diabetes

Diabetes UK use its annual Diabetes Week to raise awareness, as well as funds for, among other things, crucial research into new treatments for diabetes. One largely neglected therapeutic approach the charity has invested in is repurposing immunotherapies from other autoimmune diseases for type 1 diabetes, linked with the immune system’s role in destroying pancreatic cells.

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:


Go Top